Pfizer is first to apply for US emergency use for Covid-19 vaccine
The application also includes safety data on about 100 children 12-15 years of age. The company said 45% of US trial participants are 56-85 years old
The application also includes safety data on about 100 children 12-15 years of age. The company said 45% of US trial participants are 56-85 years old